A search for an animal model of the Spanish toxic oil syndrome

Food and Chemical Toxicology

Volumn 40, Issue 11, 2002, Pages 1551-1567

  Hard, G C ^a,b  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b NONE   (New Zealand)

Author keywords

Autoimmunity; Eosinophilia; IgE; Test species; Toxic oil syndrome; Vasculitis

Indexed keywords

4' FLUORO 10 METHYL 1,2 BENZANTHRACENE; ANILIDE; ANTHRACENE DERIVATIVE; CORTISONE ACETATE; EDETATE SODIUM; ENDOTOXIN; GLUCAN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE B4; MERCURIC CHLORIDE; METHYL ISOCYANATE; MONOCROTALINE; NITROGEN DIOXIDE; OLEOYLANILIDE; POLYMYXIN B; THROMBOCYTE ACTIVATING FACTOR; TRYPTOPHAN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

AUTOIMMUNITY; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DOG; ENDOTHELIUM INJURY; EOSINOPHILIA; HUMAN; HYPERSENSITIVITY; MYOSITIS; NECROTIZING ARTERITIS; NONHUMAN; REVIEW; TOXIC OIL SYNDROME; TOXICITY TESTING; TRANSGENIC MOUSE; VASCULITIS;

ANIMALIA; CANIS FAMILIARIS; MUS MUSCULUS; MUSTELA PUTORIUS FURO; MUSTELA VISON; TOSCANA VIRUS;

EID: 0036048430     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(02)00114-X     Document Type: Article

References (229)

1. Accumulation of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in blood and organs of the Lewis rats
2. Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airways
3. Polyarteritis in a beagle
4. Asymptomatic polyarteritis in a cynomolgus monkey
5. The toxic oil syndrome (TOS 1981): From the disease towards a toxicological understanding of its chemical aetiology and mechanism
6. Two histopathologic types of inflammatory vascular disease in MRL/Mp autoimmune mice. Model for human vasculitis in connective tissue disease
7. Eosinophilic fasciitis in a rhesus macaque
8. Immune complex vasculitis with secondary ulcerative dermatitis in aged C57BL/6NNia mice
9. Experimental leukocyte-induced pulmonary vasculitis with inquiry into mechanism
10. Frequencies of HLA-A24 and HLA-DR4-DQ8 are increased and that of HLA-B blank is decreased in chronic toxic oil syndrome
11. Arteritis of coronary arteries in mice receiving a single dose of cortisone
12. Brown Norway rat model of food allergy: Effect of plant components on the development of oral sensitization
13. Diseases of the muscle
14. The relationship between development of lung inflammation and changes in bone marrow populations in guinea-pigs following inhaled antigens
15. Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome
16. Strain-dependent cytokine profile and susceptibility to oleic acid anilide in a murine model of the Toxic Oil Syndrome
17. Compositional analysis of oil samples implicated in the Spanish Toxic Oil Syndrome
18. Animal models of vasculitis
19. Effect of fatty acid anilides on immune responses of Swiss mice
20. Role of cytokines and platelet-activating factor in microvascular immune injury
21. Attenuation of allergic airway inflammation in IL-4 deficient mice
22. Toxic oil syndrome. Experimental poisoning in the rabbit
23. Lung injury induced by antibody fragments to angiotensin-converting enzyme
24. A comparison of the acute pathology induced by 3-phenylamino-1,2-propanediol (PAP) and its mono-oleoyl ester in rodents with the toxic oil syndrome in man
25. Functional, biochemical, and histopathologic consequences of high-dose interleukin-2 administration in rats
26. Effect of PAF-antagonists on aeroallergen-induced bronchial eosinophilia in guinea pigs: A therapeutic approach
27. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in a murine model of pulmonary eosinophilia and high IgE level
28. Antithrombotic activity of nicardipine in spontaneously hypertensive rats
29. Influence of chronic hypertension on injured and uninjured arteries in spontaneously hypertensive rats
30. Eosinophils and the granulomatous reaction in rats injected with Sephadex particles
31. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat
32. Polyarteritis in a cat
33. Vascular lesions resembling polyarteritis nodosa in rats undergoing prolonged stimulation with oestrogen
34. Murine cytomegalovirus-associated arteritis
35. Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model
36. Development of pancellular toxicity in guinea pig lung by ingestion of oleylanilide
37. Autoimmune diseases associated with drugs, chemicals and environmental factors
38. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: A TH2 immunological mechanism
39. Neurotransmitter changes in cerebrospinal fluid in the Spanish toxic oil syndrome: Human clinical findings and experimental results in mice
40. Eosinophilia in transgenic mice expressing interleukin 5
41. Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndrome
42. Acute eosinophilic interstitial pulmonary disease in a pony
43. Microcytic thrombocytosis, small megakaryocytes, platelet lipids and hyperreactivity to collagen, lymphocytopenia, eosinophilia, and low blood volume in genetically hyperlipidemic rabbits
44. Tumor necrosis factor mediates disseminated intravascular inflammation (DII) in the genesis of multiple organ edema
45. The BALB/c mouse as a model for immunological studies of microfilariae-induced pulmonary eosinophilia
46. Studies of eosinophilia in dogs. II. Occurrence of eosinophilia in various diseases with the exception of digestive disorders
47. Patterns of acute vascular injury after intra-arterial barbiturate injection
48. Nutritionally induced necrotizing glomerulonephritis and polyarteritis nodosa in pigs
49. Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized Brown-Norway rats
50. Inhibition of allergen-induced lung eosinophilia by type-III and combined type III- and IV-selective phosphodiesterase inhibitors in Brown-Norway rats
51. 1,1′-Ethylidenebis[tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia-myalgia syndrome
52. Immunologic abnormalities in canine juvenile polyarteritis syndrome: A naturally occurring animal model of Kawasaki disease
53. Antineutrophil cytoplasmic antibodies (ANCA): Their role in diagnosis and pathogenesis of vasculitis
54. Eosinophilic gastroenteritis with Splendore-Hoeppli material in the ferret (Mustela putorius furo)
55. Repeated endothelial injury and induction of atherosclerosis in normolipemic rabbits by human serum
56. Immunological basis of toxic oil syndrome (TOS)
57. Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury
58. Monokine-induced acute lung injury in rabbits
59. Human recombinant interleukin-2 provokes acute pulmonary vascular endothelial injury in rabbits
60. Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1 beta
61. Pathology of two cases of canine disseminated hypereosinophilic disease
62. Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL+/+ mice
63. Role of purified IgG1 in pulmonary hypersensitivity responses of the guinea pig
64. Generalized eosinophilic myositis with eosinophilia of blood and cerebrospinal fluid in a raccoon (Procyon lotor)
65. Mononuclear cell pulmonary vasculitis in NZB/W mice II. Immunohistochemical characterization of the infiltrating cells
66. Polyarteritis in a colony of beagles
67. Eosinophilic myositis in sheep
68. Idiopathic extramural coronary arteritis in beagle and mongrel dogs
69. Renal and pulmonary alterations induced in rats by a single injection of monocrotaline
70. An idiopathic febrile necrotizing arteritis syndrome in the dog: Beagle pain syndrome
71. The guinea pig as a model for isoniazid-induced reactions
72. Systemic necrotizing vasculitis and glomerulonephritis in grower pigs in southwestern Quebec
73. A spectrum of hypereosinophilic syndromes exemplified by six cats with eosinophilic enteritis
74. A comparative study of minoxidil-induced myocardial lesions in beagle dogs and miniature swine
75. Are there environmental forms of systemic autoimmune disease?
76. Sequential study of vasculitis in MRL mice
77. Vascular changes in the kidneys of NZB mice and F1 NZBxNZW hybrids
78. Possible etiologic agents for toxic oil syndrome: Fatty acid esters of 3-(n-phenylamino)-1,2-propanediol
79. In vivo administration of antibody to murine IL-5 receptor inhibits eosinophilia of IL-5 transgenic mice
80. Induction of eosinophilic enteritis and eosinophilia in rats by vitamin E and selenium deficiency
81. Complement and endotoxin-induced lung injury in sheep
82. Methyl mercury-induced autoimmunity in mice
83. Repeated antigen challenge induces airway hyperresponsiveness with tissue eosinophilia in guinea pigs
84. Effect of murine recombinant interleukin-5 on bronchial reactivity in guinea-pigs
85. Comparative toxicity of methyl isocyanate and its hydrolytic derivatives in rats. I. Pulmonary histopathology in the acute phase
86. Pulmonary granulomatous vasculitis. Pulmonary granulomatous vasculitis induced in rats by treatment with glucan
87. Adenosine diphosphate-induced platelet aggregation and vascular injury in swine and rabbits
88. Arterial lesions in gnotobiotic mice congenitally infected with LCM virus
89. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury
90. Antigen-antibody induced cutaneous eosinophilia in complement deficient guinea-pigs
91. Classification of naturally occurring arterial disease in the dog
92. Histopathology of spontaneous panarteritis in beagle dogs
93. Toxicity of oleic acid anilide in rats
94. Heated linoleic acid anilide: Toxicity and relevance to toxic oil syndrome
95. Heated linoleic acid anilide reduces serum enzyme activities in rats
96. Toxic Oil Syndrome: A current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome
97. Human recombinant lymphokines and cytokines induce pulmonary eosinophilia in the guinea pig which is inhibited by ketotifen and AH 21-132
98. Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis
99. The analysis of angitis and nephritis in SL/Ni mouse as a model of immune complex disease - Studies on SL/Ni mouse, an animal model of PN: II
100. Immune-mediated effects upon oral challenge of ovalbumin-sensitized Brown Norway rats: Further characterization of a rat food allergy model
101. Mercury-induced autoimmunity in Brown Norway rats: Kinetics of changes in RT6+ T lymphocytes correlated with IgG isotopes of circulating autoantibodies to laminin 1
102. The production of an experimental eosinophilia in rats by hexadimethrine bromide (Polybrene)
103. Experimental eosinophilia in rats released by hexadimethrine bromide
104. Intratracheal application of Sephadex in rats leads to massive pulmonary eosinophilia without bronchial hyperreactivity to acetylcholine
105. Characterization of a murine model of allergic pulmonary inflammation
106. Mechanisms of allergic pulmonary eosinophilia in the mouse
107. IgE and eosinophil regulation in a murine model of allergic aspergillosis
108. Pathological studies on the kidney of systemic arteritis. II. Animal model: Comparative studies on the pathogenesis of arteritis and glomerulonephritis of SL/Ni and MRL/1
109. Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish Toxic Oil Syndrome
110. Inhibitory effect of cyclosporin A on eosinophil infiltration in the guinea-pig lung induced by antigen, platelet-activating factor and leukotriene B4
111. Smooth muscle cell proliferation in response to endothelial injury in coronary arteries of normal and von Willebrand's disease swine
112. Genetic control of eosinophilia. Analysis of production and response to eosinophil-differentiating factor in strains of mice infected with Trichinella spiralis
113. Genetic influences upon eosinophilia and resistance in mice infected with Mesocestoides corti
114. Airway hyper-reactivity and blood, lung and airway eosinophilia in rats treated with Sephadex particles
115. Variable expression of Lactobacillus case; cell wall-induced coronary arteritis: An animal model of Kawasaki's disease in selected inbred mouse strains
116. Experimental venous thrombosis in agranulocytic rabbits
117. Autoimmune diseases in domestic animals
118. Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma
119. Endothelial injury and platelet aggregation associated with acute lipid mobilization
120. Hypereosinophilic syndrome in cats: A report of three cases
121. Tolerance and autoimmunity
122. Induction of lung eosinophilia and neutrophilia in guinea pigs following injection of sephadex beads
123. Effects of nutrition on disease and life span. I. Immune responses, cardiovascular pathology, and life span in MRL mice
124. Prospective analysis of eosinophilia in spontaneously diabetic BB rats: Correlation with islet inflammation but not with diabetes development
125. Animal models of systemic vasculitis
126. Mercuric chloride-treated brown Norway rats develop widespread tissue injury including necrotizing vasculitis
127. Experimental steroid-induced osteonecrosis in adult rabbits with hypersensitivity vasculitis
128. Studies on the antibody producing system of SL/Ni mouse - Studies on SL/Ni mouse, an animal model of PN: III
129. Attempted induction of an avian eosinophilia using various agents
130. Ultrastructural and cytochemical studies in Japanese quail (Coturnix coturnix japonica) eosinophils and in those from birds with experimentally induced eosinophilia
131. Experimental eosinophilia in domestic fowls and ducks following horse serum stimulation
132. Endotoxin-induced pulmonary endothelial injury
133. Endothelial injury and pulmonary congestion characterize neurogenic pulmonary edema in rabbits
134. Pathogenesis of arteritis of SL/Ni mice. Possible lytic effect of anti-gp70 antibodies on vascular smooth muscle cells
135. Gastrointestinal vasculitis in autoimmune-prone (NZW X BXSB)F1 mice: Association with anticardiolipin autoantibodies
136. Eosinophilic myeloproliferative disorder in a horse
137. Chronic necrotizing vasculitis in a horse
138. Interleukin-4 induces tissue eosinophilia in mice: Correlation with its in vitro capacity to stimulate the endothelial cell-dependent selective transmigration of human eosinophils
139. Autoimmune vasculitis in MRL/Mp-lpr/lpr mice: Orthochromatic basophils participate in the development of delayed-type hypersensitivity angiitis
140. Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis
141. Hypereosinophilic syndrome in a cat
142. Toxic effects of fatty acid anilides on the oxygen defense systems of guinea pig lungs and erythrocytes
143. The pathogenesis of experimental arteritis induced by Candida alkali-extract in mice
144. Necrotizing angiitis produced by the Shwartzman mechanism
145. Pulmonary vascular lesions in chickens following intravenous injections of disintegrated cells of Escherichia coli
146. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis
147. The effect of the neurokinin antagonist FK-224 on the cough response to inhaled capsaicin in a new model of guinea-pig eosinophilic bronchitis induced by intranasal polymyxin B
148. Vascular alterations and degranulation of eosinophil leucocytes in bovine eosinophilic myositis
149. Nitrogen dioxide-induced eosinophilia and mucosal injury in the trachea of the guinea pig
150. Nitrogen dioxide-induced eosinophilia and mucosal injury in the nose of the guinea pig
151. Eosinophilic-mastocytic arteriolofibrosis in a cow
152. T-cell-dependent accumulation of eosinophils in the lung and its inhibition by monoclonal anti-interleukin-5
153. Coronary artery aneurysms develop in weanling rabbits with serum sickness but not in mature rabbits. An experimental model for Kawasaki disease in humans
154. The influence of antigen dose on IgE production in different rat strains
155. Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation
156. Predictive testing for autoimmunity
157. Toxic oil syndrome and eosinophilia myalgia syndrome. WHO meeting report
158. Production of eosinophil-rich guinea pig peritoneal exudates
159. Epidemiologic evidence for a new class of compounds associated with Toxic Oil Syndrome
160. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions
161. Pathogenesis of an experimental model of Goodpasture's haemorrhagic pneumonitis
162. Immune-complex-mediated vasculitis increases coronary artery lipid accumulation in autoimmune-prone MRL mice
163. Lymphocytic enteritis and systemic vasculitis in sheep
164. Immune-mediated vasculitis in five dogs
165. Environmentally induced autoimmune diseases: Potential mechanisms
166. Endothelial injury and regeneration. IV. Endotoxin: A nondenuding injury to aortic endothelium
167. Effect of the selective leukotriene B4 antagonists U-75302 and Ly255283 on bronchoalveolar eosinophilia induced by inhalation of leukotriene B4 or allergen in brown-Norway rats
168. Masticator myopathy in the dog. (A review of two cases)
169. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension
170. Pathologic features in mice hyposensitized to bee venom
171. Eosinophilia
172. Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability
173. Spontaneous disseminated panarteritis in laboratory beagle dogs in a toxicity study: A possible genetic predilection
174. Cytokine knockout mice: Possible application in toxicological research
175. Angiotoxic activity of 4′fluoro-10-methyl-1,2-benzanthracene in the rat
176. Morphological changes in the respiratory tract of guinea pigs exposed to kerosene aerosol
177. Toxic oil syndrome: A study of renal function in guinea pigs fed toxic oil
178. Lysosomal enzyme activities in liver and sera from guinea pigs fed oil related to the toxic oil syndrome
179. Immune complex type disease induced by HgCl2 in Brown-Norway rats: Genetic control of susceptibility
180. Subchronic toxicity of 3-phenylamino alanine, an impurity in L-tryptophan reported to be associated with eosinophilia-myalgia syndrome
181. A highly fatal vascular disease of broiler breeder chickens
182. Vascular toxicity in dogs associated with overdoses of a novel enzodiazepine receptor partial agonist
183. Eosinophilic polymyositis in a dog
184. Systemic necrotizing vasculitis in nine young beagles
185. A respiratory syndrome in cattle resulting from thrombosis of the posterior vena cava
186. Reproduction of experimental endarteritis by hormonal action
187. Experimental aortic lesions of acute serum sickness in rabbits
188. Eosinophilic myositis in a goat
189. Fiber type-specific autoantibodies in a dog with eosinophilic myositis
190. Eosinophilia caused by administration of L-tryptophan to animals with adrenal dysfunction
191. Comparative studies on tryptophan binding to hepatic nuclear envelopes in Sprague-Dawley and Lewis rats
192. A murine model of the eosinophilia-myalgia syndrome induced by 1,1′-ethylidenebis (L-tryptophan)
193. Eosinophilic myositis in Canadian cattle
194. Pulmonary eosinophilia and granulomatous pulmonary arteritis induced in rats by intravenous Sephadex
195. Periarteritis in a beagle colony
196. Mononuclear-cell pulmonary vasculitis in NZB/W mice. I. Histopathologic evaluation of spontaneously occurring pulmonary infiltrates
197. Necrotizing vasculitis as an immunological complication in toxicity study
198. Toxic oil syndrome, Spain: Effect of oleoylanilide on the release of polysaturated fatty acids and lipid peroxidation in rats
199. Periarteritis nodosa in spontaneously hypertensive rats - Incidence and distribution
200. Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline
201. Eosinophil and foam cell accumulation in lungs of Sprague-Dawley rats fed purified, biotin-deficient diets
202. Blockade of CD28/CTLA4-B7 pathway prevented autoantibody-related diseases but not lung disease in MRL/lpr mice
203. Features of renal vasculitis in autoimmune MRL lpr/lpr mice: Phenotypes and functional properties of infiltrating cells
204. Participation of eosinophilis in the toxic oil syndrome
205. Cyclophosphamide-induced eosinophilia in the rat: Concomitant changes in T-cell subsets, B cells and large granular lymphocytes within lymphoid tissues
206. Transgenic mice expressing a B cell growth and differentiating factor gene (interleukin 5) develop eosinophilia and autoantibody production
207. Necrotizing polyarteritis in aging RF mice
208. Cyclophosphamide pretreatment induces eosinophilia to nonparasite antigens
209. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs
210. Genetic control of eosinophilia. Mouse strain variation in response to antigens of parasite origin
211. Experimental allergic bronchopulmonary aspergillosis in the mouse: Immunological and histological features
212. Evidence for the role of platelet-activating factor in immune complex vasculitis in the rat
213. Periarteritis nodosa in rats treated with chronic excess sodium chloride (NaCl) after X-irradiation
214. Immune defense and eosinophilia in congenitally IgE-deficient SJA/9 mice infected with Angiostrongylus Costaricensis
215. Protective immunity and eosinophilia in IgE-deficient SJA/9 mice infected with Nippostrongylus brasiliensis and Trichinella spiralis
216. Multiple antigen challenge produces pulmonary eosinophilia but not pulmonary hyperresponsiveness in actively sensitized guinea pigs
217. Assessment of autoimmunity-inducing potential using the Brown Norway rat challenge model
218. Polyarteritis nodosa-like disease in outbred mice
219. Polyarteritis nodosa: The natural history of a spontaneously occurring model in outbred mice
220. Pulmonary arteritis induced by cationic proteins
221. Mechanisms and pathology of monocrotaline pulmonary toxicity
222. Genetic control of eosinophilia in guinea pig strains inbred for high or low bronchial allergic reactivity
223. Genetic control of eosinophilia in guinea pig strains inbred for high or low bronchial allergic reactivity. 2. A genetic study of spontaneous and immunization-induced eosinophilia
224. The proliferating cells in autoimmune MRL/lpr mice lack L3T4, an antigen on 'helper' T cells that is involved in the response to class II major histocompatibility antigens
225. Studies on morphological changes of arteries by administration of soluble immune complexes to low calcium diet bred guinea pigs. - Special reference to the morphological pathogenesis of arteritis
226. Multiple angiitis of mesenterial arteries in guinea pigs induced by intraperitoneal administration of high doses of Na2EDTA. I. Light microscopic study
227. Pulmonary infiltrates with eosinophilia syndrome in a dog
228. Spontaneous necrotizing arteritis and glomerulonephritis in mice
229. Periarteritis in experimental Border disease of sheep. I. The occurrence and distribution of the lesion